AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for HBV

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test NCT07563309NA3 sites๐Ÿ“ Johannesburg๐Ÿ“ Durban๐Ÿ“ Cape Town bioLytical Laboratories ยท Tests: TruPlex HIV/HepB/Syphilis Rapid Test Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites๐Ÿ“ Boston๐Ÿ“ Clichy๐Ÿ“ Hong Kong Precision BioSciences, Inc. ยท Tests: PBGENE-HBV Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance NCT06779864n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site๐Ÿ“ New York NYU Langone Health Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States NCT05832229Phase 213 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Institute of Diabetes and Digestive and Kidney Disโ€ฆ ยท Tests: Rosuvastatin Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) NCT03792919Phase 41 site๐Ÿ“ Hong Kong Humanity & Health Medical Group Limited ยท Tests: Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs NCT07069569Phase 214 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Fuzhou Ausper Biopharma Co., Ltd. ยท Tests: AHB-137, Peg-IFN, Hepatitis B Vaccine Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C NCT06755632NA2 sites๐Ÿ“ Bobigny๐Ÿ“ Bobigny Assistance Publique - Hรดpitaux de Paris ยท Tests: TROD (rapid diagnostic orientation test) and FibroScanยฎ Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255n/a1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: peginterferon alpha based regimen, nucleos(t)ide Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC NCT06251115NA1 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: QY-1-T TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b NCT02883647n/a1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Entecavir or Tenofovir Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria NCT06834178n/a1 site๐Ÿ“ Graz Vanessa Stadlbauer-Koellner, MD Risk Assessment for HBV-Related Liver Cancer NCT07160946n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: AI folow-up system Comparison of Viral Suppression With 0.5 mg and 1.0 mg Daily Doses of Entecavir in Decompensated HBV Cirrhosis of Liver NCT07816094Phase 41 site๐Ÿ“ Dhaka Bangladesh Medical University ยท Tests: Entecavir Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong NCT07720245NA1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Wellnuts app intervention, Web-based health resources A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. NCT05686759Phase 38 sites๐Ÿ“ Goyang-si๐Ÿ“ Suwon๐Ÿ“ Seoul GC Biopharma Corp ยท Tests: Undiluted I.V.-Hepabig inj(GC5103), Diluted I.V.-Hepabig inj(GC5103) Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project. NCT07169656n/a162 sites๐Ÿ“ Anyang๐Ÿ“ Anyang๐Ÿ“ Anyang The First Affiliated Hospital of Zhengzhou University ยท Tests: ETV,TDF,TAF,TMF, Peginterferon ฮฑ-2b injection Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon NCT06696664n/a1 site๐Ÿ“ Beijing Minghui Li ยท Tests: PEG-IFN-ฮฑ A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease. NCT05255978n/a1 site๐Ÿ“ Wuhan Qin Ning Peg IFNฮฑ-2b Therapy for Unresectable Mid to Late Stage HBV-HCC NCT07769827NA1 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Combined Peg IFNฮฑ-2b treatment group Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Nucleos(t)ide Analogs (NA) DELTA DESCRIBE: the French Collaborative Project NCT05936073n/a1 site๐Ÿ“ Limoges University Hospital, Limoges ยท Tests: Patients co-infected HBV/HDV The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection NCT07240350n/a1 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: Tissue resection SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus NCT06364930Phase 41 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Dapagliflozin 10mg Tab, Placebo 10mg Tab Liver Disease and Other Systemic Diseases NCT04525833n/a1 site๐Ÿ“ New Taipei City Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B NCT07200193Phase 1, Phase 24 sites๐Ÿ“ Lyon๐Ÿ“ Hong Kong๐Ÿ“ Auckland nChroma Bio ยท Tests: CRMA-1001 Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077Phase 41 site๐Ÿ“ Baltimore Mercy Medical Center ยท Tests: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease NCT02863757n/a1 site๐Ÿ“ Hong Kong Humanity and Health Research Centre Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis NCT07413549Phase 1, Phase 21 site๐Ÿ“ Wuhan Beijing Tuohua Weiye Biotechnology Co., Ltd. ยท Tests: Human Umbilical Cord Mesenchymal Stem Cells Injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy